Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07637448
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Southern Medical University Nanfang Hospital Department of Oncology Guangzhou, Guangdong, China
NCT07348965
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
- Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
NCT05257967
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
NCT05948813
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +8 more
- Locations
-
- National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
NCT06363734
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Department of Thoracic Medical Oncology, Tianjin Medical University Cancer Hospital Tianjin, Tianjin Municipality, China
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Angers - CHU Angers, France
- Bayonne - CH Bayonne, France
- Boulogne - Ambroise Paré Boulogne, France
- Lyon - URCOT Bron, France
NCT05382728
- Conditions
- EGFR Activating Mutation, NSCLC
- Locations
-
- Hunan Provincial Tumor Hospital Changsha, Hunan, China
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
NCT05768490
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +8 more
- Locations
-
- Sun-Yat-Sen university Guangdong, Guangzhou, China
Enrolling by Invitation
Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
NCT06730477
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
- Union hospital, Tongji Medical college, Huazhong University of Science and Technology Wuhan, Hubei, China
Not Yet Recruiting
First-line Therapy With EGFR-TKI Combined With Trastuzumab Rezetecan for Advanced NSCLC Harboring EGFR Mutations Concomitant With HER2 Alterations
NCT07699952
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC
NCT07685197
- Conditions
- EGFR Activating Mutation, EGFR-TKI-resistant Non-Small Cell Lung Cancer, NSCLC, +2 more
- Locations
-
Not specified
Not Yet Recruiting
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
NCT07287904
- Conditions
- Adenocarcinoma, Adenocarcinoma Lung, Adenocarcinoma of Lung, +16 more
- Locations
-
- Wuhan Union Hospital Wuhan, Hubei, China
Not Yet Recruiting
High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC
NCT07182708
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
NCT05778149
- Conditions
- Anlotinib, Aumolertinib, EGFR Activating Mutation, +2 more
- Locations
-
Not specified
NCT04233021
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +11 more
- Locations
-
- Centre Hospitalier Aix-Pertuis Aix-en-Provence, France
- CHU Amiens - Groupe Hospitalier Sud Amiens, France
- Centre Paul Papin Angers, France
- Hôpital privé d'Antony Antony, France
NCT05146219
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +11 more
- Locations
-
- National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
NCT04764214
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Completed
EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression
NCT03544814
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
Not specified
Active, Not Recruiting
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
NCT05258279
- Conditions
- EGFR Activating Mutation, Non-squamous Non-small-cell Lung Cancer
- Locations
-
- Juntendo Urayasu Hospital Urayasu, Chiba, Japan
- St. Marianna University Hospital Kawasaki, Kanagawa, Japan
- Kanagawa Cardiovascular and Respiratory Center Yokohama, Kanagawa, Japan
- Kanagawa Cancer Center Yokohama, Kanagawa, Japan
Active, Not Recruiting
Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC
NCT05244213
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China